Study of the Evolution of the Expression of the LAMP-2 Protein During the Advance in Age

Centre Hospitalier Universitaire de Nice

Status: Enrolling

Conditions: Aging

Treatments: Diagnostic Test: dosage

Study type: Interventional

Funder types: Other

Identifiers

NCT06357923

2024-A00321-46 (Other Identifier)

23-PP-13

Details and patient eligibility

About

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1.

Full description

Recruitment on the RAV pole in consultation or day hospital. Competitive recruitment of subjects > 60 years of age respecting a male/female ratio = 1. After explanations and collection consent, collection of the patient's socio-demographic and medical characteristics and then carrying out a Peripheral venous blood sample (2 x 5ml tubes).

Enrollment: 100 estimated patients

Sex: All

Ages: 60 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women over 60 years of age.

Exclusion criteria

• Inability to Understand Consent,
• Non-Security Beneficiaries
• social, subjects protected by law, subjects deprived of liberty,
• history of breast cancer,
• brain tumor,
• melanoma,
• colon cancer,
• lung cancer,
• prostate cancer,
• lymphoma,
• myeloma,
• syndrome myelodysplastic/myeloproliferative,
• leukemia,
• history of radiation therapy.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

evaluation of LAMP-2 protein expression

Other group

Description:

dosing of level expression of LAMP-2

Treatment:

Diagnostic Test: dosage